ABclonal Competitors and Similar CompaniesClear all

ABclonal's competitors and similar companies include genesig, Cipla, EMS Pharma and Alembic Pharmaceuticals.

	ABclonal ABclonal is a company providing antibodies, proteins, ELISA kits, NGS prep kits, and molecular enzymes.	genesig genesig is a provider of qPCR kits for pathogen detection, veterinary testing, meat speciation, and more.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.	Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
Founding Date	Founding Date 2011	Founding Date N/A	Founding Date 1935	Founding Date 1964	Founding Date 2010
Type	Type Private	Type Subsidiary	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Manufacturing & Industrial biotech clinical research	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations HQ Woburn, US	Locations Chandler's Ford, GB HQ Camberley, GB Plymouth Meeting, US	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations BR HQ	Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN
Employees	Employees 1151% increase	Employees N/A	Employees 27,764	Employees 12,7441% increase	Employees 14,858
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) ₹73.4b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹95.5b (FY, 2026)	Cost of goods N/A	Cost of goods ₹19.8b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ₹195b (FY, 2026)	Gross profit N/A	Gross profit ₹54.1b (FY, 2026)
Net income	Net income N/A	Net income N/A	Net income ₹38.7b (FY, 2026)	Net income N/A	Net income ₹6.7b (FY, 2026)
Operating ⚠
Products	Products N/A	Products N/A	Products 1.5 k (FY, 2024)	Products N/A	Products 145 (FY, 2024)